Business / Finance

RSS

Practices for expediting corporate market research approval process for faster insights

Delays in the launch and execution of critical market research projects can slow down the decision-making process, resulting in missed opportunities and increased costs. It is, therefore, absolutely critical for biopharmaceutical companies to develop a tactical approach to expedite the market research approval process for quicker and more meaningful insights.

29 Aug 2015

CytomX announces filing of registration statement for proposed initial public offering of common stock

CytomX Therapeutics, Inc., a biopharmaceutical company developing Probody therapeutics for the treatment of cancer, today announced the filing of a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its common stock.

29 Aug 2015

Vee Technologies named among top 500 fastest growing companies in U.S.

New York based global services Vee Technologies, made it to the top 500 fastest growing companies in U.S., as per the 34th Annual List of Inc 500. The company has a staggering 944% growth over a 3-year period.

29 Aug 2015

Perrigo: Shareholders may reject Mylan' offer

Perrigo Company plc today commented on the Mylan N.V. shareholder vote regarding its planned unsolicited offer to acquire Perrigo.

29 Aug 2015

Perrigo closes acquisition of leading OTC brands from GSK

Perrigo Company plc today announced that it has completed the acquisition of leading OTC brands from GSK in an all cash transaction valued at €200 million. The transaction is a clear demonstration of Perrigo's unique ability to maximize brand value across the Company's leading European distribution network spanning 36 countries.

28 Aug 2015

Mylan receives shareholders' approval for proposed Perrigo acquisition

Mylan N.V. today announced that its shareholders have approved Mylan's proposed acquisition of Perrigo Company plc and the related issuance of Mylan ordinary shares to Perrigo's shareholders at an extraordinary general meeting of shareholders held today.

28 Aug 2015

Can-Fite BioPharma announces Q2 financial results for 2015, updates drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the six months ended June 30, 2015 and updates on its drug development programs.

28 Aug 2015

Physio announces acquisition of Therapy Plus, debt restructuring through GE Capital's HFS

Physiotherapy Corporation announced today that it has acquired Therapy Plus, a seven-facility physical and occupational therapy provider in Milwaukee, WI. This follows its recent integration with the Anderson Orthopedic Clinics in northern Virginia and a joint venture with Central Iowa Healthcare in Marshalltown, IA.

28 Aug 2015

Global urinary catheters market to expand at 4.1% CAGR between 2015 and 2021

According to a new market report published by Persistence Market Research titled "Global Market Study on Urinary Catheters: Intermittent Catheters Segment to Witness Highest Growth by 2021", the urinary catheters market is expected to be valued at US$1,377.5 Mn by the end of 2015. It is anticipated to expand at a CAGR of4.1% from 2015 to 2021, to reach US$1,755.0 Mn by 2021.

From B. Braun Melsungen AG 27 Aug 2015

Sigma-Aldrich signs agreement with PHE to manufacture, supply bacterial and fungal NCTC/NCPF CRMs

Sigma-Aldrich Corporation, a leading Life Science and Technology Company, today announced it has signed an agreement with Public Health England to manufacture and supply bacterial and fungal NCTC/NCPF Certified Reference Materials (CRM) in LENTICULE disc format worldwide for use as controls in food, water, environmental and clinical testing microbiology laboratories.

27 Aug 2015

Edwards Lifesciences closes acquisition of CardiAQ Valve Technologies

Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced that it has closed its acquisition of CardiAQ Valve Technologies, Inc., a privately held company and developer of a transcatheter mitral valve replacement system. Edwards announced last month that it had signed an agreement to acquire CardiAQ.

27 Aug 2015

iCo Therapeutics incurs total comprehensive loss of $738,607 for second quarter 2015

iCo Therapeutics, today reported financial results for the quarter ended June 30, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").

27 Aug 2015

U.S. Renal Care, DSI Renal sign definitive merger agreement

U.S. Renal Care, Inc. and DSI Renal announced Monday they have entered into a definitive merger agreement. USRC is the third largest dialysis provider in the country, and when combined with DSI, the company will serve approximately 23,000 patients across 33 states and the Territory of Guam.

26 Aug 2015

Lannett's net sales rise 23% to $99.3 million in fourth quarter fiscal 2015

Lannett Company, Inc. today reported financial results for its fiscal 2015 fourth quarter and full year ended June 30, 2015. On June 1, 2015, the company completed the acquisition of Silarx Pharmaceuticals, Inc. The financial results presented below include approximately one month of operations for Silarx, which were not material.

26 Aug 2015

BD Life Sciences completes acquisition of Cellular Research

BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company), today announced it has completed the acquisition of Cellular Research, Inc.

From BD (Becton, Dickinson and Company) 26 Aug 2015

Kewaunee Scientific's sales up 2% in first quarter 2015

Kewaunee Scientific Corporation today reported results for its first quarter ended July 31, 2015.

26 Aug 2015

Shire enters into agreement with Sanquin for CINRYZE

Shire plc announced today it has entered into an agreement with Sanquin Blood Supply, the manufacturer of CINRYZE (C1 esterase inhibitor [human]), providing Shire access to its manufacturing technology and allowing Shire to source additional manufacturers to meet the growing demand for CINRYZE.

25 Aug 2015

MNX Global Logistics' new Life Sciences Logistics Centre opens in Amsterdam

MNX Global Logistics announces the opening of its dedicated supply chain and logistics facility in Amsterdam, the Netherlands, located just outside of Amsterdam Airport Schiphol. This facility with validated temperature-controlled supply chain capabilities will serve as the operations and warehousing hub for our Life Sciences and Medical Device customers throughout Europe.

25 Aug 2015

Inovalon signs definitive agreement to acquire Avalere Health

Inovalon, a leading technology company providing advanced, cloud-based data analytics and data-driven intervention platforms to the healthcare industry, has entered into a definitive agreement to acquire Avalere Health, Inc., a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.

25 Aug 2015

Ascendis Pharma's total revenue decreases 50% to €1.9 million in second quarter 2015

Ascendis Pharma A/S, a clinical stage biotechnology company that applies its innovative TransCon technology to address significant unmet medical needs, today announced financial results for the three and six months ended June 30, 2015.

25 Aug 2015